---
title: Quality of Life After Laparoscopic Removal of Essure®
nct_id: NCT03281564
overall_status: COMPLETED
sponsor: Hospices Civils de Lyon
study_type: OBSERVATIONAL
primary_condition: Contraceptive Device; Complications
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03281564.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03281564"
ct_last_update_post_date: 2023-11-13
last_seen_at: "2026-05-12T07:23:28.884Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Quality of Life After Laparoscopic Removal of Essure®

**Official Title:** Prospective Study of Quality of Life After Laparoscopic Removal of Essure®

**NCT ID:** [NCT03281564](https://clinicaltrials.gov/study/NCT03281564)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 474
- **Lead Sponsor:** Hospices Civils de Lyon
- **Conditions:** Contraceptive Device; Complications, Quality of Life
- **Start Date:** 2017-10-14
- **Completion Date:** 2023-10-17
- **CT.gov Last Update:** 2023-11-13

## Brief Summary

A lot of patients seem to complain after hysteroscopic tubal occlusion by Essure® device with a worce quality of life. Investigators' hypothesis is that Essure® laparoscopic removal may improve quality of life. This prospectice study aim to assess the quality of life 1, 3, 6 and 12 months after Essure® removal.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* women aged 18 years or more
* patients with Essure® sterilization device
* surgical removal of Essure® with bilateral salpingectomy by laparoscopy

Exclusion Criteria:

* interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.
* impaired lower-limb range of motion preventing positioning for surgery
* inability to understand information provided
* prisoner or under administrative supervision.
```

## Arms

- **Essure®** — Patients with laparoscopic removal of Essure®

## Interventions

- **Quality of life after Essure® removal** (OTHER) — Questionnaire to assess the quality of life 1, 3, 6 and 12 months after laparoscopic removal of Essure® device

## Primary Outcomes

- **Quality of life 1 month after laparoscopic removal of Essure®** _(time frame: 1 month)_ — Questionnaire to assess the quality of life 1 month after laparoscopic removal of Essure® device

## Locations (1)

- Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France

## Recent Field Changes (last 30 days)

- `eligibility.sex` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.gynaecology department, hôpital femme mère enfant, hospices civils de lyon|bron||france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03281564.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03281564*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*